Rare diseases
Investigational molecules
Locations
379 conditions with trials, the busiest first
1 276 trials across Europe, recruiting first
Study on the Effects of Inhaled Treprostinil for Patients with Idiopathic Pulmonary Fibrosis
BelgiumStudy on Trametinib Dimethyl Sulfoxide for Children with Refractory Histiocytosis Not Responding to Conventional Treatment
PolandStudy on Vemurafenib for Children with BRAF Mutation-Resistant Histiocytosis
PolandStudy of Sitravatinib and Nivolumab vs. Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Chemotherapy and Checkpoint Inhibitor Therapy
ItalyStudy of Sotatercept for Patients with Severe Pulmonary Arterial Hypertension at High Risk of Mortality
BelgiumStudy on the Effects of Dexpramipexole in Adolescents and Adults with Eosinophilic Asthma
PolandStudy on Long-term Safety and Efficacy of Elexacaftor, Tezacaftor, and Ivacaftor in Children and Adults with Cystic Fibrosis Aged 2 Years and Older
GermanyStudy on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis
AustriaStudy of Pembrolizumab with Cisplatin or Carboplatin and Pemetrexed for Patients with Resectable Malignant Pleural Mesothelioma
ItalyStudy of Encorafenib and Binimetinib for Patients with BRAF V600-Mutant Non-Small Cell Lung Cancer
ItalyStudy on the Effects of AZD4604 on Airway Inflammation in Adults with Asthma
DenmarkStudy of JDQ443, TNO155, and Tislelizumab for Patients with Advanced Solid Tumors with KRAS G12C Mutation
BelgiumThe therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
